Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1979 2
1980 1
1981 1
1982 1
1986 1
1987 2
1988 2
1990 4
1992 5
1993 2
1996 2
1997 3
1998 5
1999 5
2000 3
2001 9
2002 4
2003 9
2004 15
2005 12
2006 13
2007 11
2008 14
2009 19
2010 33
2011 37
2012 33
2013 28
2014 38
2015 31
2016 35
2017 39
2018 32
2019 30
2020 44
2021 56
2022 52
2023 49
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

622 results

Results by year

Filters applied: . Clear all
Page 1
Effects of Omega-3 Fatty Acids on Flow-mediated Dilatation and Carotid Intima Media Thickness: A Meta-analysis.
Lee YS, Park JW, Joo M, Moon S, Kim K, Kim MG. Lee YS, et al. Curr Atheroscler Rep. 2023 Oct;25(10):629-641. doi: 10.1007/s11883-023-01137-8. Epub 2023 Aug 8. Curr Atheroscler Rep. 2023. PMID: 37552456 Review.

RECENT FINDINGS: FMD was significantly higher in the omega-3 fatty acid group compared to the control group (mean difference = 0.90%; p = 0.0003). In particular, the subgroup with CHD (both EPA + DHA < 1 g/day and 1 g/day) and the subgroup without CHD but with CH

…
RECENT FINDINGS: FMD was significantly higher in the omega-3 fatty acid group compared to the control group (mean difference = 0.90%; p = 0. …
Enhanced recovery protocols for ambulatory surgery.
Cukierman DS, Cata JP, Gan TJ. Cukierman DS, et al. Best Pract Res Clin Anaesthesiol. 2023 Sep;37(3):285-303. doi: 10.1016/j.bpa.2023.04.007. Epub 2023 Apr 23. Best Pract Res Clin Anaesthesiol. 2023. PMID: 37938077 Review.
These data suggest an expected rise in the volume of ambulatory (same day) or extended ambulatory (23 h) surgeries in coming years. Similar increases are also observed in other countries. For example, 75% of elective surgeries are performed as same-day surgery in th …
These data suggest an expected rise in the volume of ambulatory (same day) or extended ambulatory (23 h) surgeries in coming years. S …
Development of the juxta-oral organ in rat embryo.
Velasco JR, De La Cuadra Blanco C, Velasco JA. Velasco JR, et al. Anat Rec (Hoboken). 2012 May;295(5):769-75. doi: 10.1002/ar.22444. Epub 2012 Mar 19. Anat Rec (Hoboken). 2012. PMID: 22431151 Free article.
The aim of this work is to clarify the development and morphology of the juxta-oral organ (JOO) in rat embryos from Day (E)14 to 19. Furthermore, in the region of the JOO, an analysis was made of the expression of the monoclonal antibody HNK-1, which recogniz …
The aim of this work is to clarify the development and morphology of the juxta-oral organ (JOO) in rat embryos from Day (E)14 …
Ureteroscopy: anesthetic considerations.
Cybulski PA, Joo H, Honey RJ. Cybulski PA, et al. Urol Clin North Am. 2004 Feb;31(1):43-7, viii. doi: 10.1016/S0094-0143(03)00087-9. Urol Clin North Am. 2004. PMID: 15040400 Review.
Ureterorenoscopy (URS) is a vital procedure in the armamentarium of the modern-day urologist for the management of ureteral and renal pathology. ...
Ureterorenoscopy (URS) is a vital procedure in the armamentarium of the modern-day urologist for the management of ureteral and renal …
Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial.
Kelly K, Altorki NK, Eberhardt WE, O'Brien ME, Spigel DR, Crinò L, Tsai CM, Kim JH, Cho EK, Hoffman PC, Orlov SV, Serwatowski P, Wang J, Foley MA, Horan JD, Shepherd FA. Kelly K, et al. J Clin Oncol. 2015 Dec 1;33(34):4007-14. doi: 10.1200/JCO.2015.61.8918. Epub 2015 Aug 31. J Clin Oncol. 2015. PMID: 26324372 Clinical Trial.
PATIENTS AND METHODS: An international randomized, double-blind, placebo-controlled study was conducted in patients with completely resected IB to IIIA NSCLC whose tumors expressed EGFR protein by immunohistochemistry or EGFR amplification by fluorescence in situ hybridization. P …
PATIENTS AND METHODS: An international randomized, double-blind, placebo-controlled study was conducted in patients with completely resected …
Electroacupuncture for abdominal pain relief in patients with acute pancreatitis: A three-arm randomized controlled trial.
Kee Jang D, Kyu Lee J, Yung Jung C, Ho Kim K, Ra Kang H, Sun Lee Y, Hwa Yoon J, Ro Joo K, Kyu Chae M, Hyeon Baek Y, Seo BK, Hyub Lee S, Lim C. Kee Jang D, et al. J Integr Med. 2023 Nov;21(6):537-542. doi: 10.1016/j.joim.2023.10.004. Epub 2023 Nov 2. J Integr Med. 2023. PMID: 37973472 Clinical Trial.
VAS score change (median [interquartile range]) on day 5 was (12.3 22.5) in the EA1 group, (10.3 21.5) in the EA2 group, and (8.9 15.2) in the control group. ...Please cite this article as: Jang DK, Lee JK, Jung CY, Kim KH, Kang HR, Lee YS, Yoon JH, Joo KR, Chae MK, …
VAS score change (median [interquartile range]) on day 5 was (12.3 22.5) in the EA1 group, (10.3 21.5) in the EA2 group, and (8.9 15. …
Establishment and verification of a mouse model of nasal wound healing.
Joo YH, Jeon SY, An HJ, Cho HJ, Kim JH, Jung MH, Kim RB, Park JJ, Kim SW. Joo YH, et al. Laryngoscope. 2019 Aug;129(8):E266-E271. doi: 10.1002/lary.27821. Epub 2019 Jan 23. Laryngoscope. 2019. PMID: 30675728
On day 14, synechiae featuring neo-osteogenesis (bone lacunae, osteoblasts, and multinucleated osteoclasts) between the septum and the maxilloturbinate were prominent, followed by wound maturation on day 28: fewer lacunae and smaller osteoblasts. Macrophages were ev …
On day 14, synechiae featuring neo-osteogenesis (bone lacunae, osteoblasts, and multinucleated osteoclasts) between the septum and th …
Idiopathic Retroperitoneal Hematoma with Spontaneous Resolution.
Hwang YJ, Jin SJ, Jeong YJ, Myung HJ, Shin HY, Kim HD, Joo YE. Hwang YJ, et al. Korean J Gastroenterol. 2021 Nov 25;78(5):295-299. doi: 10.4166/kjg.2021.106. Korean J Gastroenterol. 2021. PMID: 34824188 Free article.
The size of the hematoma decreased from 9.0 cm to 5.8 cm on the following CT. He could begin to eat food on the 26th admission day, and he was discharged on the 31st admission day. The hematoma disappeared entirely on the following CT. ...
The size of the hematoma decreased from 9.0 cm to 5.8 cm on the following CT. He could begin to eat food on the 26th admission day, a …
Machine learning based estimation of urban on-road CO2 concentration in Seoul.
Park C, Jeong S, Kim C, Shin J, Joo J. Park C, et al. Environ Res. 2023 Aug 15;231(Pt 3):116256. doi: 10.1016/j.envres.2023.116256. Epub 2023 May 26. Environ Res. 2023. PMID: 37245580
High spatiotemporal inhomogeneity of hourly CO(2)(traffic) over Seoul, with 14.3 ppm by time-of-day and 345.1 ppm by road, was apparent in the CO(2)(traffic) data predicted by the model. ...
High spatiotemporal inhomogeneity of hourly CO(2)(traffic) over Seoul, with 14.3 ppm by time-of-day and 345.1 ppm by road, was appare …
Health-related quality-of-life analyses from a multicenter, randomized, double-blind phase 2 study of patients with differentiated thyroid cancer treated with lenvatinib 18 or 24 mg/day.
Taylor MH, Leboulleux S, Panaseykin Y, Konda B, de La Fouchardiere C, Hughes BGM, Gianoukakis AG, Park YJ, Romanov I, Krzyzanowska MK, Garbinsky D, Sherif B, Pan JJ, Binder TA, Sauter N, Xie R, Brose MS. Taylor MH, et al. Cancer Med. 2023 Feb;12(4):4332-4342. doi: 10.1002/cam4.5308. Epub 2022 Dec 4. Cancer Med. 2023. PMID: 36464853 Free PMC article. Clinical Trial.
BACKGROUND: In the phase 2 double-blind Study 211, a starting dose of lenvatinib 18 mg/day was compared with the approved starting dose of 24 mg/day in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC). ...CONCLUSIONS: In Study 211, HRQoL f …
BACKGROUND: In the phase 2 double-blind Study 211, a starting dose of lenvatinib 18 mg/day was compared with the approved starting do …
622 results